Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Regulatory News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

8 Nov 2016 16:40

RNS Number : 6669O
4d Pharma PLC
08 November 2016
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APMUWSNRNRAARAA
Date   Source Headline
2nd Aug 20217:00 amRNSTwo MRx0518 presentations accepted for ESMO 2021
29th Jul 20217:00 amRNS$30 Million Credit Facility with Oxford Finance
26th Jul 20211:00 pmRNSPassing of Chief Financial Officer John Beck
6th Jul 20217:00 amRNSPublication - LBP improves activity of CAR-T
29th Jun 20217:00 amRNSLadenburg Thalmann Healthcare Conference
22nd Jun 20217:00 amRNSConference presentation on LBP Manufacturing’
4th Jun 20217:00 amRNSAsthma trial Part A enrolment and program update
1st Jun 20218:52 amRNSTotal Voting Rights
24th May 202110:48 amRNSResult of AGM
24th May 20217:00 amRNSUpdate on Data for Phase II Study of Blautix
17th May 20217:00 amRNSPresentation of Blautix IBS Phase II at DDW 2021
19th Apr 20217:00 amRNSCollaboration with Parkinson’s UK
16th Apr 20217:00 amRNSDirectors’ Subscription for new Ordinary Shares
15th Apr 20215:00 pmRNSAnnual Financial Report
15th Apr 20217:00 amRNSParticipation in Jefferies Therapeutics Summit
12th Apr 20212:26 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSHow to Convert AIM Ordinary Shares into Nasdaq ADS
1st Apr 20217:00 amRNSFinal Results
26th Mar 20213:21 pmRNSHolding(s) in Company
25th Mar 202112:08 pmRNSHolding(s) in Company
25th Mar 20218:00 amRNSHolding(s) in Company
22nd Mar 20217:00 amRNSCompletion of Merger
18th Mar 20211:25 pmRNSResult of Meeting
17th Mar 20211:00 pmRNS4D Pharma Announces Private Placement
3rd Mar 20217:00 amRNSInvestor conference participation
1st Mar 20215:49 pmRNSExercise of Options and Total Voting Rights
1st Mar 20217:02 amRNSJohn Beck Appointed as Chief Financial Officer
1st Mar 20217:00 amRNSAppoints Paul Maier to the Board as NED
26th Feb 202112:52 pmRNSHolding(s) in Company
26th Feb 20217:02 amRNSPosting of Circular
26th Feb 20217:00 amRNSU.S. SEC Declares Registration Statement Effective
16th Feb 20217:00 amRNSMicrobiome Leaders Panel Event
8th Feb 20217:45 amRNSHolding(s) in Company
8th Feb 20217:00 amRNSOncology Clinical Collaboration
4th Feb 20212:55 pmRNSHolding(s) in Company
3rd Feb 20217:00 amRNSOncology Program Update
1st Feb 20212:10 pmRNSTotal Voting Rights
27th Jan 20217:00 amRNSHolding(s) in Company
25th Jan 20216:01 pmRNSHolding(s) in Company
21st Jan 20217:00 amRNSConference participation
30th Dec 20208:32 amRNSHolding(s) in Company
29th Dec 20205:17 pmRNSHolding(s) in Company
29th Dec 20202:24 pmRNSHolding(s) in Company
22nd Dec 20202:31 pmRNSHolding(s) in Company
18th Dec 20208:53 amRNSJoins MJFF-sponsored Parkinson’s study consortium
27th Nov 20203:42 pmRNSHolding(s) in Company
26th Nov 20207:09 amRNSRegistration Statement filed with SEC
23rd Nov 20207:00 amRNSLongevity extends Business Combination deadline
12th Nov 202012:18 pmRNSHolding(s) in Company
9th Nov 20206:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.